And the expression of PDK4 was up-regulated in LDL-treated CD14+ monocytes, suggesting that PDK4 might be involved in inducement of aberrant glycolysis in LDL-treated CD14+ monocytes and associated with abnormal activation of CD14+ monocytes in CAD patients. This evidence concerns the gene CD14 and coronary artery disorder.